These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3923949)

  • 1. High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures.
    Hunziker T; Nydegger UE; Späth PJ; Gerber HA; Hess M; Wiesmann U; Krebs A
    Arch Dermatol Res; 1985; 277(4):299-303. PubMed ID: 3923949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.
    Schiltz JR; Michel B
    J Invest Dermatol; 1976 Aug; 67(2):254-60. PubMed ID: 950490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organ culture model for the study of pemphigus acantholysis.
    Michel B; Ko CS
    Br J Dermatol; 1977 Mar; 96(3):295-302. PubMed ID: 322692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal acantholysis induced in vitro by pemphigus autoantibody. An ultrastructural study.
    Hu CH; Michel B; Schiltz JR
    Am J Pathol; 1978 Feb; 90(2):345-62. PubMed ID: 564142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody.
    Schiltz JR; Michel B; Papay R
    J Invest Dermatol; 1979 Dec; 73(6):575-81. PubMed ID: 512411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis.
    Morioka S; Naito K; Ogawa H
    J Invest Dermatol; 1981 May; 76(5):337-41. PubMed ID: 7014725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis.
    Jeffes EW; Kaplan RP; Ahmed AR
    J Clin Immunol; 1984 Sep; 4(5):359-63. PubMed ID: 6541659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone inhibits pemphigus acantholysis in skin cultures.
    Swanson DL; Dahl MV
    J Invest Dermatol; 1983 Sep; 81(3):258-60. PubMed ID: 6886473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
    Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
    Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding site of pemphigus vulgaris antibodies and their fate during acantholysis.
    Iwatsuki K; Takigawa M; Imaizumi S; Yamada M
    J Am Acad Dermatol; 1989 Apr; 20(4):578-82. PubMed ID: 2469704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of IgA pemphigus antigen in human skin and the role of IgA anti-cell surface antibodies in the induction of intraepidermal acantholysis.
    Supapannachart N; Mutasim DF
    Arch Dermatol; 1993 May; 129(5):605-8. PubMed ID: 8481022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W; Hashimoto K; Toi Y
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathologic and histologic studies on skin from pemphigus patients in tissue culture.
    Chorzelski TP; Rogozinski T; Sulej J
    J Cutan Pathol; 1979 Apr; 6(2):130-3. PubMed ID: 383751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence.
    Mascaró JM; España A; Liu Z; Ding X; Swartz SJ; Fairley JA; Diaz LA
    Clin Immunol Immunopathol; 1997 Oct; 85(1):90-6. PubMed ID: 9325074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro.
    Schiltz JR; Hu CH; Michel B
    Br J Dermatol; 1979 Sep; 101(3):279-84. PubMed ID: 389269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.